Terns Pharmaceuticals Inc (TERN)
5.905
-0.24
(-3.83%)
USD |
NASDAQ |
May 17, 16:00
5.905
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Total Liabilities (Quarterly): 10.05M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 10.05M |
December 31, 2023 | 13.15M |
September 30, 2023 | 13.26M |
June 30, 2023 | 15.55M |
March 31, 2023 | 13.60M |
December 31, 2022 | 10.08M |
September 30, 2022 | 8.892M |
June 30, 2022 | 7.644M |
Date | Value |
---|---|
March 31, 2022 | 7.953M |
December 31, 2021 | 7.767M |
September 30, 2021 | 7.734M |
June 30, 2021 | 6.675M |
March 31, 2021 | 9.239M |
December 31, 2020 | 23.70M |
September 30, 2020 | 42.26M |
December 31, 2019 | 19.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.675M
Minimum
Jun 2021
42.26M
Maximum
Sep 2020
13.58M
Average
10.06M
Median
Total Liabilities (Quarterly) Benchmarks
Viking Therapeutics Inc | 33.63M |
Eli Lilly and Co | 51.05B |
Pfizer Inc | 128.54B |
Amgen Inc | 87.96B |
Madrigal Pharmaceuticals Inc | 231.52M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 246.77M |
Shareholders Equity (Quarterly) | 236.72M |